• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Design of E.coli expressed stalk domain immunogens of H1N1 HA that protect mice from lethal challenge

tetano

Editor, Senior Moderator
J Virol. 2012 Sep 26. [Epub ahead of print]
Design of E.coli expressed stalk domain immunogens of H1N1 HA that protect mice from lethal challenge.
Bommakanti G, Lu X, Citron MP, Najar TA, Heidecker GJ, Ter Meulen J, Varadarajan R, Liang X.
Source

Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.
Abstract

The hemagglutinin protein (HA) on the surface of influenza virus is essential for viral entry into the host cells. The HA1 subunit of HA is also the primary target for neutralizing antibodies. The HA2 subunit is less exposed on the virion surface and more conserved than HA1. We have previously designed an HA2 based immunogen derived from the sequence of the H3N2 A/HK/68 virus. In the present study we report the design of an HA2 based immunogen from the H1N1 subtype (PR/8/34). This immunogen (H1HA0HA6) and its circular permutant (H1HA6) were well folded and provided complete protection against homologous viral challenge. Anti-sera of immunized mice showed cross-reactivity with HA proteins of different strains and subtypes. Although no neutralization was observable in a conventional neutralization assay, sera of immunized guinea pigs competed with a broadly neutralizing antibody CR6261 for binding to recombinant Viet/04 HA protein suggesting that CR6261 like antibodies were elicited by the immunogens. Stem domain immunogens from a seasonal H1N1 strain (A/NC/20/99) and a recent pandemic strain (A/Cal/07/09) provided cross-protection against A/PR/8/34 viral challenge. HA2 containing stem domain immunogens therefore have the potential to provide subtype specific protection.

PMID:
23015722
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23015722
 
Back
Top Bottom